Patients beware of pharmaceutical danger: FDA alert for anesthetic Propofol
The Federal Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDCP) have issued an alert regarding Propofol, and anesthetic commonly known as Diprivan. Several clusters of patients have reported experiencing chills, fever and body aches after being administered the drug. If you or someone you know has received Propofol for sedation of general anesthesia and subsequently experienced fever, chills, and body aches or other symptoms please make a report to the MedWatch program. Those patients should also be evaluated for bacterial sepsis. At this point, no product liability lawsuits have been filed.
Click here to view the FDA alert
Bookmark: 
